Rivaroxaban twice daily for lysis of left atrial appendage thrombus: a potential new therapeutic option.
Roman
R
Piotrowski
Beata
B
Zaborska
Jakub
J
Baran
Małgorzata
M
Sikora-Frąc
Piotr
P
Kułakowski
D020517:Atrial Appendage / Q000000981:diagnostic imaging / Q000187:drug effects*; D001281:Atrial Fibrillation / Q000150:complications*; D003328:Coronary Thrombosis / Q000150:complications* / Q000000981:diagnostic imaging / Q000188:drug therapy; D017548:Echocardiography, Transesophageal; D065427:Factor Xa Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D000069552:Rivaroxaban / Q000008:administration & dosage / Q000627:therapeutic use*
D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban